In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae (Q40488931)

21 September 2017

In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae (English)

1 reference

21 September 2017

carbapenem antibiotic

0 references

0 references

3

Patrice Nordmann

1 reference

21 September 2017

1

Laurent Poirel

1 reference

21 September 2017

2

Nicolas Kieffer

1 reference

PubMed ID

26416781

21 September 2017

language of work or name

English

0 references

publication date

27 September 2015

1 reference

Journal of Antimicrobial Chemotherapy

21 September 2017

1 reference

21 September 2017

71

1 reference

21 September 2017

1

1 reference

21 September 2017

156-161

1 reference

Carbapenem resistance in Enterobacteriaceae: here is the storm!

21 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV294

Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV294

Global spread of Carbapenemase-producing Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV294

Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV294

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV294

The emerging NDM carbapenemases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV294

OXA-48-like carbapenemases: the phantom menace

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV294

Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV294

Impact of various conditions on the efficacy of dual carbapenem therapy against KPC-producing Klebsiella pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV294

Efficacy of humanized carbapenem exposures against New Delhi metallo-β-lactamase (NDM-1)-producing enterobacteriaceae in a murine infection model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV294

Phenotypic and biochemical comparison of the carbapenem-hydrolyzing activities of five plasmid-borne AmpC β-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV294

Heterogeneous hydrolytic features for OXA-48-like β-lactamases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV294

In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV294

In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV294

Comparison of Techniques for Measurement of in Vitro Antibiotic Synergism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV294

Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV294

Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV294

Double-carbapenem therapy for carbapenemase-producing Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV294

Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV294

Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV294

Metallo-β-lactamase structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV294

Double-carbapenem therapy not proven to be more active than carbapenem monotherapy against KPC-positive Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV294

21 January 2018

Identifiers

DOI

10.1093/JAC/DKV294

1 reference

release_kjjlyhozqzb3jatv4fk7sodj5u

21 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kjjlyhozqzb3jatv4fk7sodj5u

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

26416781

1 reference

PubMed ID

26416781